↓ Skip to main content

Dove Medical Press

Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, March 2011
Altmetric Badge

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
56 Mendeley
Title
Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder
Published in
ClinicoEconomics and Outcomes Research: CEOR, March 2011
DOI 10.2147/ceor.s17846
Pubmed ID
Authors

Xianchen Liu, Yi Chen, Douglas E Faries

Abstract

THIS STUDY COMPARED ADHERENCE AND PERSISTENCE OF THREE BRANDED ANTIDEPRESSANTS: the serotonin and norepinephrine reuptake inhibitors (SNRIs) duloxetine and venlafaxine XR, and the selective serotonin reuptake inhibitor (SSRI) escitalopram; and generic selective SSRIs, and examined demographic and clinical predictors of adherence and persistence in patients with major depressive disorder in usual care settings.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 2%
Unknown 55 98%

Demographic breakdown

Readers by professional status Count As %
Other 11 20%
Researcher 9 16%
Student > Bachelor 7 13%
Student > Ph. D. Student 6 11%
Student > Postgraduate 6 11%
Other 13 23%
Unknown 4 7%
Readers by discipline Count As %
Medicine and Dentistry 23 41%
Nursing and Health Professions 7 13%
Psychology 4 7%
Biochemistry, Genetics and Molecular Biology 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 10 18%
Unknown 6 11%